• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在辅助受孕周期的黄体期给予雌二醇对孕酮分泌的抑制作用。

Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles.

作者信息

Tay P Y, Lenton E A

机构信息

Department of Obstetrics and Gynaecology, University of Malaya, 50603, Kuala Lumpur.

出版信息

Med J Malaysia. 2003 Jun;58(2):187-95.

PMID:14569738
Abstract

A prospective randomised study was done to assess the effect of supplemental oestradiol in addition to progesterone on the luteal steroid profiles and pregnancy outcome in stimulated cycles with and without pituitary down regulation. Women undergoing stimulated cycle IVF with GnRH-a and FSH (Group A, n = 63) or stimulated intrauterine insemination using CC and FSH (Group B, n = 55) were studied. These subjects were randomly allocated to receive either 400 mg daily of vaginally administrated Cyclogest (progesterone) alone or in combination with 2 mg daily of oral Oestradiol Valerate (E2V) during the luteal phase. Significant lower concentrations of plasma progesterone were observed in those subjects supplemented with both E2V and progesterone compared to those in whom progesterone only was given during the luteal phase (P < 0.05). Exogenous E2V had a minimal impact on plasma oestradiol concentrations and did not disguise the characterised mid luteal decline in oestradiol secretion. The suppressive effect of E2V on plasma progesterone was lost if implantation occurred normally because any small change in steroid concentrations was reversed by the rapidly increasing concentrations of HCG. Similar pregnancy rates were observed among subjects supplemented with or without oestradiol. The addition of oestradiol to the luteal supplement suppresses endogenous corpus luteum progesterone secretion irrespective of the type of assisted conception cycle and that its use is unlikely to be beneficial to the process of implantation.

摘要

进行了一项前瞻性随机研究,以评估在有或没有垂体降调节的刺激周期中,除孕酮外补充雌二醇对黄体类固醇谱和妊娠结局的影响。研究了接受促性腺激素释放激素激动剂(GnRH-a)和促卵泡素(FSH)进行刺激周期体外受精的女性(A组,n = 63)或使用克罗米芬(CC)和FSH进行刺激宫内人工授精的女性(B组,n = 55)。这些受试者在黄体期被随机分配接受每天400mg经阴道给药的黄体酮(Cyclogest),单独使用或与每天2mg口服戊酸雌二醇(E2V)联合使用。与仅在黄体期给予孕酮的受试者相比,补充E2V和孕酮的受试者血浆孕酮浓度显著降低(P < 0.05)。外源性E2V对血浆雌二醇浓度影响最小,并且没有掩盖黄体中期雌二醇分泌的特征性下降。如果正常发生着床,E2V对血浆孕酮的抑制作用就会消失,因为类固醇浓度的任何微小变化都会被快速升高的人绒毛膜促性腺激素(HCG)浓度逆转。补充或不补充雌二醇的受试者中观察到相似的妊娠率。在黄体期补充剂中添加雌二醇会抑制内源性黄体孕酮分泌,无论辅助受孕周期的类型如何,并且其使用不太可能对着床过程有益。

相似文献

1
Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles.在辅助受孕周期的黄体期给予雌二醇对孕酮分泌的抑制作用。
Med J Malaysia. 2003 Jun;58(2):187-95.
2
The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles.黄体期补充剂对刺激体外受精周期后妊娠结局的影响。
Med J Malaysia. 2005 Jun;60(2):151-7.
3
Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.黄体期雌二醇/孕酮替代可提高促排卵周期的妊娠率——但仅适用于年轻女性。
Early Pregnancy (Cherry Hill). 2000 Jan;4(1):64-73.
4
Luteal phase support may improve pregnancy outcomes during intrauterine insemination cycles.黄体期支持可能会改善宫腔内人工授精周期中的妊娠结局。
Eur J Obstet Gynecol Reprod Biol. 2011 Jul;157(1):57-62. doi: 10.1016/j.ejogrb.2011.03.022. Epub 2011 Apr 21.
5
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.黄体期支持对宫腔内人工授精周期妊娠率的影响:一项前瞻性随机研究。
Fertil Steril. 2009 Jun;91(6):2508-13. doi: 10.1016/j.fertnstert.2008.04.029. Epub 2008 Aug 9.
6
Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.体外受精-卵胞浆内单精子注射患者黄体期补充雌二醇:一项随机对照试验。
Fertil Steril. 2008 Dec;90(6):2190-5. doi: 10.1016/j.fertnstert.2007.10.021. Epub 2008 Jan 14.
7
Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.在接受促性腺激素释放激素拮抗剂/rFSH刺激进行体外受精的患者中,添加雌二醇至孕酮进行黄体期补充:一项随机对照试验。
Hum Reprod. 2006 Oct;21(10):2628-32. doi: 10.1093/humrep/del117. Epub 2006 Jul 20.
8
GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.促性腺激素释放激素激动剂作为新型黄体支持:一项使用鼻内给予布舍瑞林的随机、平行组、可行性研究的结果
Hum Reprod. 2005 Jul;20(7):1798-804. doi: 10.1093/humrep/deh830. Epub 2005 May 12.
9
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.黄体期给予促性腺激素释放激素(GnRH)激动剂对接受GnRH激动剂和拮抗剂治疗的卵巢刺激周期中卵胞浆内单精子注射(ICSI)后胚胎着床的有益作用。
Hum Reprod. 2006 Oct;21(10):2572-9. doi: 10.1093/humrep/del173. Epub 2006 Aug 22.
10
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.在多囊卵泡发育病例中,低剂量人绒毛膜促性腺激素用于GnRH激动剂触发排卵后黄体支持的安全性和有效性。
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22.

引用本文的文献

1
Luteal phase support for in vitro fertilization/intracytoplasmic sperm injection fresh cycles: a systematic review and network meta-analysis.黄体期支持在体外受精/卵胞浆内单精子注射新鲜周期中的应用:系统评价和网络荟萃分析。
Reprod Biol Endocrinol. 2021 Jul 6;19(1):103. doi: 10.1186/s12958-021-00782-5.
2
A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.在使用促性腺激素释放激素拮抗剂方案的患者中,三种黄体期支持方案联合雌激素对体外受精-胚胎移植结局影响的比较。
JBRA Assist Reprod. 2019 Aug 22;23(3):239-245. doi: 10.5935/1518-0557.20190012.
3
Luteal phase support for assisted reproduction cycles.
辅助生殖周期的黄体期支持。
Cochrane Database Syst Rev. 2015 Jul 7;2015(7):CD009154. doi: 10.1002/14651858.CD009154.pub3.
4
Preimplantation and postimplantation therapy for the treatment of reproductive failure.用于治疗生殖功能衰竭的植入前和植入后疗法。
J Hum Reprod Sci. 2013 Apr;6(2):88-92. doi: 10.4103/0974-1208.117165.